About Pulmocide
Pulmocide is developing novel inhaled medicines for serious respiratory diseases
Company Details
Corporate & Operational Profile
Web & Domain Identity
Social & Network Presence
Company Milestones & Timeline
- Capital Raise
Raised $52,000,000 · Series-B+
fundraisingfox.com
- Capital Raise
Raised $92,000,000 · Series-B+
- Milestone
X account created (@PulmocideLtd)
33 followers
- Capital Raise
Raised $30,400,000 · Series-B+
- Milestone
Company founded
London, United Kingdom
- Milestone
Website domain registered
pulmocide.com
Investors & Backers
Funding History
Founders & Leadership
Ashish Sagrolikar
Chief Commercial Officer
Dan Burgess
Chairman and Chief Executive Officer
Garth Rapeport
Cofounder
Jennifer Cayer
Chief Business Officer
John Murray
Cofounder
Kazuhiro Ito
Cofounder
Pete Strong
Chief Scientific Officer and Cofounder
Press Coverage & Sources
fundraisingfox.com/companies/pulmocide
biotechnologynewsmagazine.infomeddnews.com/pulmocide-raises-92-million-series-c-financing/
genengnews.com/topics/drug-discovery/pulmocide-raises-30-4m-for-clinical-development-of-inhaled-respiratory-drugs/
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Hexagon Bio
hexagonbio.com
RefloDx
reflodx.com
HeyVoli
heyvoli.com
CureBay
curebay.com
4Tissue
4tissue.com